U.S. ECMO Machine Market Summary

The U.S. extracorporeal membrane oxygenation (ECMO) machine market size was valued at USD 79.9 million in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 5.40% from 2024 to 2030. This growth is primarily driven by the increasing incidence of cardiopulmonary and respiratory diseases, along with a rising number of patients diagnosed with chronic obstructive pulmonary disease (COPD). Additionally, continuous advancements in ECMO machine technologies are enhancing clinical outcomes and boosting their adoption among healthcare professionals, thereby propelling the market forward during the forecast period.

The U.S. ECMO machine market contributed 26.0% of the global extracorporeal membrane oxygenation machine market share in 2023. The increasing prevalence of respiratory diseases has significantly influenced this growth. Various respiratory conditions such as bronchiectasis, hypersensitivity pneumonitis, lung fibrosis, asthma, COPD, and lung cancer continue to impact a substantial portion of the population. Among these, COPD ranks as the third leading cause of death in the United States, trailing only cancer and cardiovascular diseases. According to the American Lung Association, over 11 million individuals in the U.S. are diagnosed with COPD each year. The heightened prevalence of COPD has substantially increased the demand for ECMO machines, exceeding the current market supply.

Key Market Trends & Insights

• In 2023, the oxygenators segment held the largest market share at 36% and is anticipated to maintain its dominant position throughout the forecast period. The segment's growth is driven by the increasing occurrence of pulmonary diseases and the growing acceptance of ECMO machines as a standard part of advanced critical care procedures in hospitals and intensive care units.
• The veno-arterial ECMO modality accounted for the largest market share in 2023 and is expected to register the fastest CAGR over the forecast period. This is attributed to the increasing requirement for cardiac support in cases of cardiac arrest and circulatory collapse. Furthermore, this modality is frequently employed in the treatment of severe conditions such as pulmonary embolism and pulmonary hypertension, particularly during acute decompensation episodes, thus increasing its adoption among healthcare providers.
• Adults represented the largest patient demographic in the ECMO machine market in 2023, capturing a 59.0% share. This dominance can be explained by the growing geriatric population in the U.S., which is particularly vulnerable to cardiac and respiratory ailments. As age-related diseases become more prevalent, the need for ECMO therapy among adult and elderly patients continues to rise significantly.
• Respiratory applications led the U.S. ECMO machine market in 2023, holding a 48.0% share. The extensive application of ECMO machines for pulmonary support in cases of severe respiratory failure plays a major role in the segment’s growth. Given their critical function in assisting or replacing failing lungs, ECMO systems are increasingly utilized to stabilize patients and provide life-saving support until recovery or further interventions can occur.

Order a free sample PDF of the U.S. ECMO Machine Market Intelligence Study, published by Grand View Research.

Market Size & Forecast

• 2023 Market Size: USD 79.9 million
• 2030 Projected Market Size: USD 114.7 million
• CAGR (2024 - 2030): 5.40%

Key Companies & Market Share Insights

The U.S. Extracorporeal Membrane Oxygenation Machine industry competition is expected to intensify due new product development, advancement in existing products, and the implementation of price reduction strategies. Companies are likely to focus on increasing their market share by enhancing marketing efforts through the sales teams of respective players. Additionally, collaborations and partnerships among key industry players are anticipated to drive aggressive competition in the market over the forecast period.

Key Players

• Inspira
• Abbott
• Terumo Cardiovascular Systems Corporation
• CytoSorbents Corporation
• Cyberonics, Inc
• OriGen
• GOHIBIC™
• Agilent Technologies
• Soma Tech Intl
• Mott Corporation

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion

In conclusion, the U.S. ECMO machine market is witnessing consistent growth driven by the rising burden of cardiopulmonary and respiratory conditions, including the significant prevalence of COPD. Technological advancements are increasing the reliability and effectiveness of ECMO therapy, making it a preferred option for critical care. Key segments such as oxygenators, veno-arterial modalities, and respiratory applications are expected to remain dominant. With growing adoption among adult patients and increasing clinical acceptance, ECMO is playing an essential role in improving survival outcomes. This positions the U.S. market as a critical contributor to the global ECMO landscape in the coming years.